The Institut Pasteur and Merieux Alliance Company Profile

20:29 EDT 27th March 2015 | BioPortfolio

The Institut Pasteur is one of the world's leading biomedical research centre. Founded by Louis Pasteur in 1887, it is a private, non-profit foundation dedicated to the prevention and treatment of diseases through biological research, education and public-health activities. Close to 2,600 people work on its campus in Paris, where a large part of its research activities are devoted to infectious diseases and 10% focuses on AIDS research. The Paris institute is the heart of an International Network made up that unites 30 institutes across all five continents. Over a period of 120 years, 10 Institut Pasteur researchers have received the Nobel Prize, the latest of these in 2008, when it was awarded to Professors Francoise Barre-Sinoussi and Luc Montagnier for the discovery of the Aids virus.


News Articles [577 Associated News Articles listed on BioPortfolio]

Sanofi and the Institut Pasteur reward four researchers for their influential work in the life sciences

Sanofi and the Institut Pasteur awarded the Sanofi - Institut Pasteur awards for the third consecutive year. Four internationally renowned researchers were honored today for their work carried out in ...

Merieux closes EUR150M healthcare fund

Merieux Developpement, the private equity arm of Institut Merieux, has launched its second evergreen healthcare fund with EUR150 million ($187.4 million). The fund includes a EUR75 million contributio...

Moderna, Institut Pasteur enter research collaboration for new mRNA vaccines

US-based developer of messenger RNA (mRNA) Therapeutics Moderna Therapeutics has entered into long-term strategic research collaboration with Institut Pasteur to discover and develop drugs and vaccine...

Ergebnisse der Impfstoffstudie von Themis Bioscience gegen das Chikungunya-Virus in The Lancet Infectious Diseases veröffentlicht

Der Impfstoffkandidat, der im Rahmen einer F&E-Kooperation zwischen Themis Bioscience GmbH und dem Institut Pasteur entwickelt wurde, zeigt in einer Phase-I-Studie gute Ergebnisse im Hinblick auf ...

Moderna Therapeutics, Valera, Institut Pasteur deal

Institut Pasteur, Myriad Genetics deal

Myriad RBM Joins Institut Pasteur in the Global Fight Against Tuberculosis

SALT LAKE CITY, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Myriad RBM, a wholly owned subsidiary of Myriad Genetics, Inc. (Nasdaq:MYGN), today announced that it will assist the Institut Pasteur in a public-pr...

Chikungunya Vaccine Succeeds in Phase I: Paving the way for a new generation of vaccines

Themis Bioscience and the Institut Pasteur announce positive chikungunya vaccine results in phase I using revolutionary measles vector Vienna-based Themis Bioscience, and the Paris based Institut Past...

PubMed Articles [119 Associated PubMed Articles listed on BioPortfolio]

Dear prudence.

Article highlight based on "Th2-type inflammation under conditions of pre-existing chronic disease is associated with liver damage in patients with avian influenza H7N9 virus" by Jiankang Han et al.

Tuberculosis in Papua New Guinea: from yesterday until today.

Little is known about the situation of tuberculosis in Papua New Guinea despite its high TB burden, emerging drug resistance and rising HIV co-infection. This review gives an overview on the current s...

Child, Caregiver, and Therapist Perspectives on Therapeutic Alliance in Usual Care Child Psychotherapy.

This study examined the temporal stability and cross-informant agreement on multiple perspectives of child and caregiver alliance with therapists in usual care psychotherapy. Baseline predictors of al...

Valley Fever: Danger Lurking in a Dust Cloud.

Coccidioides immitis and Coccidioides posadasii contribute to the development of Valley Fever. The ability of these fungal pathogens to evade the host immune system creates difficulty in recognition a...

Relationship between defense mechanism and therapeutic alliance.

The therapeutic alliance can be defined as a collaborative relationship between the patient and the practitioner. It represents an essential component of the psychotherapeutic process (Ambresin et al....

Clinical Trials [54 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Intervention to Reduce Injection Drug Use

This is a five-year prospective randomized trial comparing two intervention conditions designed to facilitate substance abuse treatment entry and enhance retention in order to reduce the b...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on v...

Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTaP-IPV combined vaccines as a three-dose primary vaccination at 2, 4 and 6 months of age ...

Companies [482 Associated Companies listed on BioPortfolio]

The Institut Pasteur and Merieux Alliance

The Institut Pasteur is one of the world's leading biomedical research centre. Founded by Louis Pasteur in 1887, it is a private, non-profit foundation dedicated to the prevention and treatment of...

institut merieux

With extensive experience in industrial microbiology, Institut Merieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it ...

Institut Pasteur

The Institut Pasteur is a non-profit foundation dedicated to the prevation and treatment of diseases through biological research,education and public health activites

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

Parteurop

Parteurop is a partner of choice in the life sciences business thanks to its seasoned, experienced team and its international network.Parteurop’s core practices are focused on consulting, private eq...

More Information about "The Institut Pasteur and Merieux Alliance" on BioPortfolio

We have published hundreds of The Institut Pasteur and Merieux Alliance news stories on BioPortfolio along with dozens of The Institut Pasteur and Merieux Alliance Clinical Trials and PubMed Articles about The Institut Pasteur and Merieux Alliance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Institut Pasteur and Merieux Alliance Companies in our database. You can also find out about relevant The Institut Pasteur and Merieux Alliance Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Public Health
Latest News Clinical Trials Research Drugs Reports Corporate
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The mains areas of public health are epidemiology, biostatistics...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record